20 (AIDX) Common Equity (2024 - 2026)

20 posted quarterly Common Equity of $2.6 million for Q1 2026, up 140.18% year-on-year from $1.1 million in Q1 2025, and up 13378.99% on a QoQ basis from -$19225.0 in Q4 2025.

20 (AIDX) has 3 years of Common Equity data on file, last reported at $2.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Common Equity rose 140.18% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 140.18% YoY), and the FY2025 full-year result was -$19225.0, down 101.28% from the prior year.
  • Common Equity for Q1 2026 stood at $2.6 million, up from -$19225.0 in the prior quarter.
  • Across five years, Common Equity topped out at $2.6 million in Q1 2026 and bottomed at -$19225.0 in Q4 2025.
  • The 3-year median for Common Equity is $1.3 million (2024), against an average of $1.3 million.
  • The widest annual swing landed in 2025, when Common Equity slumped 101.28%; it then soared 140.18% in 2026.
  • A 3-year view of Common Equity shows it stood at $1.5 million in 2024, then plunged by 101.28% to -$19225.0 in 2025, then surged by 13378.99% to $2.6 million in 2026.
  • The last three Common Equity figures came in at $2.6 million (Q1 2026), -$19225.0 (Q4 2025), and $1.1 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 52.70 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.98 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 48.99 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.68 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.20 Bn
10 20 - - 62,884.00 2.55 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.55 Mn
Dec 31, 2025 -19,225.00
Dec 31, 2024 1.51 Mn